I'll answer and then stay away for a bit as people probably won't like my view.
For a company to grow it needs continuous growing revenue, yes?
What has LDX got?
ViraDx - to be scrapped after stocks run out
FebriDx - which currently can only be sold in 10% of it's target market and is not exactly selling in huge numbers - a grand total of $1.2 million last financial year.
Under the current IP contracts there is no ongoing revenue after the contracts are completed.
If LDX has to rely on current sales of products they go bust tomorrow.
$1.2 mil doesn't cut it with no new IP agreements.
Thats why the SP is where it is - the ongoing revenue is virtually nil.
Now WE know that there is probably a 99% chance that LDX will get stonking great 'royalty' contracts with Hologic and Burnett. Possibly a huge BARDA contract too.
But until they are signed, there is nothing.
That's why the SP is 4c and that's why much won't change until there is ongoing growing revenue from Hologic, Burnett, FebriDx and hopefully BARDA.
Unfortunately people aren't going to chase after a stock that doesn't have the contracts yet.
Give it 12 - 18 months and everything changes. Hopefully sooner.
I appreciate this post won't be popular, but getting cranky at me doesn't change the truth of where LDX are right now.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)